Tim McCarthy, Chairman of Immupharma #IMM - 180418

Apr 19, 01:52 PM

Tim McCarthy, Chairman of Immupharma #IMM discusses the topline results of the Lupuzor Pivotal Phase III Trial.

ImmuPharma PLC is a pharmaceutical development company focusing on developing novel medicines in specialist markets with serious unmet need. Lupuzor™ is the company’s most advanced drug in development and is a treatment for lupus, a life threatening autoimmune disease and has now commenced its Phase III pivotal trial. This is only part of our story as our scientists and researchers are developing drugs to make life changing difference to people’s lives worldwide.

Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.

#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Finance #Business #Podcast

https://www.voxmarkets.co.uk/